Viewing profile — prog_1

enough for what?

im glad for you and every single patient that benefits from something i work on. From the public health angle of most eu countries investment into novel cancer treatments makes a l…

not "war on cancer" and not "we" winning. It's pharma finding ways how to profit from rare treatment successes of few rare disease types. Majority, and by majority i mean over 80%,…

you surely mean that both are ensemble models. RFs and GBMs differ in how they fit the data

ie when you cant beat them, make new metrics and you can absolutely evaluate how smart someone is in a 2min casual conversation. You wont be able to tell how well they are in some …

levins work is great, except that afaik it hasnt been reproduced outside of his lab

this really depends who you are listening to, eg compare some archetypical bigroom corporate techno performer like Charlotte deWitte vs some crate digger like Om Unit, or since we …

continuous bioreactors are a pain to operate due to high risk of contamination, need for precise environment control and validation protocols. They have also been known for decades…

moderation is the key combine and synthesize the best of antifragility, postmodernism, dao te ching, science and what have you this article made step #2 of thesis, antithesis, synt…

Doesn't anybody have a problem that the nature of their approach is first and foremost prohibition?